Pfizer and BioNTech said on Tuesday they started a clinical trial to test a new version of their vaccine specifically designed...
PfizerBioNTech
Pfizer and BioNTech say a three-shot course of their COVID-19 vaccine was able to neutralize the new omicron variant in a...
FRANKFURT -- BioNTech SE said on Friday it expects more data on a worrying new coronavirus variant detected in South...
OTTAWA -- Health Canada has approved a booster of Pfizer-BioNTech's COVID-19 vaccine for people over the age of 18. The...
Pfizer Inc. and BioNTech SE submitted initial trial data for their COVID-19 vaccine in children aged 5 to 11 to...
Pfizer Inc. and BioNTech said on Monday their COVID-19 vaccine induced a robust immune response in five- to 11-year-olds, and...